Eran Ovadya
Director of Finance/CFO at NUREXONE BIOLOGIC INC.
Net worth: 198 475 $ as of 29/04/2024
Eran Ovadya active positions
| Companies | Position | Start | End |
|---|---|---|---|
| NUREXONE BIOLOGIC INC. | Director of Finance/CFO | 14/06/2022 | - |
Career history of Eran Ovadya
Former positions of Eran Ovadya
| Companies | Position | Start | End |
|---|---|---|---|
| VVT Medical Ltd. | Director of Finance/CFO | - | - |
Silexion Therapeutics Ltd.
 Silexion Therapeutics Ltd. BiotechnologyHealth Technology Silenseed Ltd. operates as a biopharmaceutical company. Its programs include SiG12D-LODER for pancreatic cancer, and Prostate-LODER, GBM-LODER for brain cancer. The company was founded by Dr. Amotz Shemi and Prof. Eithan Galun on November 30, 2008 and is headquartered in Modi’in, Israel. | Director of Finance/CFO | - | - |
Statistics
International
| Israel | 3 |
| Canada | 2 |
Operational
| Director of Finance/CFO | 3 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| NUREXONE BIOLOGIC INC. | Health Technology |
| Private companies | 2 |
|---|---|
Silexion Therapeutics Ltd.
Silexion Therapeutics Ltd. BiotechnologyHealth Technology Silenseed Ltd. operates as a biopharmaceutical company. Its programs include SiG12D-LODER for pancreatic cancer, and Prostate-LODER, GBM-LODER for brain cancer. The company was founded by Dr. Amotz Shemi and Prof. Eithan Galun on November 30, 2008 and is headquartered in Modi’in, Israel. | Health Technology |
| VVT Medical Ltd. |
- Stock Market
- Insiders
- Eran Ovadya
- Experience